Association of MicroRNAs and YRNAs with platelet function

作者: Dorothee Kaudewitz , Philipp Skroblin , Lukas H. Bender , Temo Barwari , Peter Willeit

DOI: 10.1161/CIRCRESAHA.114.305663

关键词:

摘要: Rationale: Platelets shed microRNAs (miRNAs). Plasma miRNAs change on platelet inhibition. It is unclear whether plasma miRNA levels correlate with function. Objective: To link small RNAs to reactivity. Methods and Results: Next-generation sequencing of in revealed 2 peaks at 22 23 32 33 nucleotides corresponding YRNAs, respectively. Among predominantly, fragments RNY4 RNY5 were detected. YRNAs measured 125 patients a history acute coronary syndrome who had undergone detailed assessment function 30 days after the event. Using quantitative real-time polymerase chain reactions, 92 assessed different antiplatelet therapies. Key platelet-related correlated tests. MiR-223 ( r p=0.28; n=121; P =0.002), miR-126 p=0.22; =0.016), other abundant showed significant positive correlations vasodilator-stimulated phosphoprotein phosphorylation assay. miR-126, miR-223 also among showing greatest dependency platelets strongly P-selectin, factor 4, basic protein population-based Bruneck study (n=669). A single-nucleotide polymorphism that facilitates processing pri-miR-126 mature accounted for rise circulating activation markers. Inhibition mice reduced aggregation. MiR-126 directly indirectly affects ADAM9 P2Y12 receptor expression. Conclusions: Levels tests markers general population. Alterations affect reactivity. # Novelty Significance {#article-title-46}

参考文章(58)
Mingcong Wang, Christina J. Herrmann, Milan Simonovic, Damian Szklarczyk, Christian Mering, Version 4.0 of PaxDb: Protein abundance data, integrated across model organisms, tissues, and cell‐lines PROTEOMICS. ,vol. 15, pp. 3163- 3168 ,(2015) , 10.1002/PMIC.201400441
Patrizia Ferroni, Silvia Riondino, Natale Vazzana, Nicole Santoro, Fiorella Guadagni, Giovanni Davì, Biomarkers of platelet activation in acute coronary syndromes. Thrombosis and Haemostasis. ,vol. 108, pp. 1109- 1123 ,(2012) , 10.1160/TH12-08-0550
Erik Lerkevang Grove, Robert F. Storey, Morten Wurtz, Platelet function testing in atherothrombotic disease Current Pharmaceutical Design. ,vol. 18, pp. 5379- 5391 ,(2012) , 10.2174/138161212803251862
Marcia R. Cominetti, Ana Carolina B.M. Martin, Juliana U. Ribeiro, Ibtissem Djaafri, Françoise Fauvel-Lafève, Michel Crépin, Heloisa S. Selistre-de-Araujo, Inhibition of platelets and tumor cell adhesion by the disintegrin domain of human ADAM9 to collagen I under dynamic flow conditions. Biochimie. ,vol. 91, pp. 1045- 1052 ,(2009) , 10.1016/J.BIOCHI.2009.05.012
Sho Ninomiya, Mitsuoki Kawano, Takashi Abe, Tatsuya Ishikawa, Masayuki Takahashi, Masato Tamura, Yoshiaki Takahashi, Masayuki Nashimoto, Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines. PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0118631
Christian Weber, Heidi Noels, Atherosclerosis: current pathogenesis and therapeutic options Nature Medicine. ,vol. 17, pp. 1410- 1422 ,(2011) , 10.1038/NM.2538
Anna Zampetaki, Manuel Mayr, MicroRNAs in Vascular and Metabolic Disease Circulation Research. ,vol. 110, pp. 508- 522 ,(2012) , 10.1161/CIRCRESAHA.111.247445
Harsh Dweep, Carsten Sticht, Priyanka Pandey, Norbert Gretz, miRWalk - Database: Prediction of possible miRNA binding sites by walking the genes of three genomes Journal of Biomedical Informatics. ,vol. 44, pp. 839- 847 ,(2011) , 10.1016/J.JBI.2011.05.002